Invesco Ltd. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$69,000
+13.1%
51,274
-4.7%
0.00%
Q4 2018$61,000
-51.6%
53,787
+17.7%
0.00%
Q3 2018$126,000
-22.2%
45,687
+0.9%
0.00%
Q2 2018$162,000
-50.0%
45,282
-11.9%
0.00%
Q4 2017$324,000
-8.2%
51,382
-0.5%
0.00%
Q3 2017$353,000
+3.8%
51,639
+8.4%
0.00%
Q2 2017$340,000
-57.8%
47,633
-45.7%
0.00%
Q1 2017$806,000
+475.7%
87,682
+152.8%
0.00%
Q4 2016$140,000
+17.6%
34,690
+11.7%
0.00%
Q3 2016$119,000
-10.5%
31,067
+0.7%
0.00%
Q2 2016$133,000
-93.8%
30,843
-31.3%
0.00%
-100.0%
Q2 2015$2,129,000
+29.4%
44,883
-0.0%
0.00%0.0%
Q1 2015$1,645,000
+18.9%
44,895
+28.9%
0.00%0.0%
Q4 2014$1,383,000
-11.5%
34,817
-55.5%
0.00%0.0%
Q3 2014$1,562,000
+2197.1%
78,303
+1466.1%
0.00%
Q4 2013$68,000
+47.8%
5,000
+25.0%
0.00%
Q3 2013$46,0004,0000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders